Tori Marsh - August 07, 2018
Over the past nine months, prices for brand drugs have spiked substantially—by about 30%. According to the GoodRx Index, the average cash price for a 30-day supply of the top 100 brand-name drugs increased from $300 in October to over $400 in July.
One of the biggest pharmacy benefit managers (PBM), Express Scripts, just announced that they will be dropping coverage for over 48 new drugs. This is bad news for many Americans who might find themselves on the hook for a drug that continues to increase in price. See More
Tori Marsh - July 10, 2018
The GoodRx Index also showed the following drug trends in June:
- Fills for allergy medications are dropping off.
- Actimmune continues to be the most expensive drug in the US.
This data reflects overall US prescriptions (not fills using GoodRx) and comes from several sources, including pharmacies and insurers, providing a representative sample of nationwide US prescription drug volume. See More
Tori Marsh - June 13, 2018
Patients often turn to generic medications for cheaper alternatives to brand-name drugs, but over the past couple years, prices for generics have increased substantially, and some of the most expensive generic medications run above $100 for a month’s supply. Every year, people are paying more for them despite insurance coverage due to high deductibles and formulary changes.
Tori Marsh - June 08, 2018
As if charging people over $15,000 per month for two specialty medications wasn’t already enough, manufacturer Bayer increased their prices by 8% in May to over $18,000 per month, according to a GoodRx analysis.
The GoodRx Index also showed the following drug trends in May:
Tori Marsh - May 10, 2018
Every month, it seems as if there is a new outrage over the ever-soaring cost of prescription drugs. But which drugs actually cost the most? Here are the 11 most expensive outpatient drugs, as of May 2018, based on list prices for a typical one-month prescription.
The 11 drugs on this list are all priced well over $25,000 for a monthly supply, and treat diseases rare diseases that afflict few people in the US. See More
Marie Beaugureau - December 19, 2017
In 2015, Americans spent $1,200 per capita on prescription medications, the highest rate in the world. In the U.S. a 30-day prescription to Xarelto (used to treat blood clots) costs $292, on average – where that same prescription costs just $126 in the UK, $102 in Switzerland, and just $48 in South Africa, according to a 2016 survey by the International Federation of Health Plans. A 28-day supply of Humira, used for Crohn’s disease and rheumatoid arthritis, costs a whopping $2,669 in the US – but just $822 in Switzerland and $1,362 in the UK. See More
Roni Shye - October 13, 2017
These price increases, among others, have shed necessary light on price hiking and transparency, and have caused many states to take this matter into their own hands. At the moment, 23 states are stepping up their efforts on drug pricing by proposing bills that take on the rising cost of drug pricing. See More
Roni Shye - October 25, 2016
The increased cost of prescription drugs has been all over the news—and a topic for debate in the 2016 elections.
Huge price hikes for medications like EpiPen, Thiola, and Daraprim, just to name a few, have left Americans frustrated and angry. Amid the controversy, some states (including California and Ohio) are trying to address drug pricing on the ballot this fall—a bold move that other states will likely follow. See More
Elizabeth Davis - December 29, 2015
2015 was another tough year for American’s health care budgets. Insurance premiums increased, coverage was dropped for a number of important drugs, and overall we’re spending more for our health care.
Don’t break out the antidepressants yet—it’s not all bad news. A number of important drugs went generic, which will generally mean huge savings and lower costs. Plus, a large number of drugs actually decreased in price. See More
Roni Shye - September 30, 2015
If you’ve been following the news, huge price increases on necessary drugs like Daraprim and cycloserine may seem unusual—they both dropped in price again once people noticed and complained, right?
The unfortunate reality as that price increases happen in the pharmaceutical industry day-in and day-out. While the majority aren’t quite as dramatic as the Daraprim price hike, they happen more often than you might think. See More